BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26460951)

  • 1. Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer.
    Bansal N; Petrie K; Christova R; Chung CY; Leibovitch BA; Howell L; Gil V; Sbirkov Y; Lee E; Wexler J; Ariztia EV; Sharma R; Zhu J; Bernstein E; Zhou MM; Zelent A; Farias E; Waxman S
    Oncotarget; 2015 Oct; 6(33):34087-105. PubMed ID: 26460951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
    Kwon YJ; Petrie K; Leibovitch BA; Zeng L; Mezei M; Howell L; Gil V; Christova R; Bansal N; Yang S; Sharma R; Ariztia EV; Frankum J; Brough R; Sbirkov Y; Ashworth A; Lord CJ; Zelent A; Farias E; Zhou MM; Waxman S
    Mol Cancer Ther; 2015 Aug; 14(8):1824-36. PubMed ID: 26078298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A-PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1.
    Kadamb R; Leibovitch BA; Farias EF; Dahiya N; Suryawanshi H; Bansal N; Waxman S
    Transl Oncol; 2022 Feb; 16():101320. PubMed ID: 34968869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancer.
    Bansal N; Bosch A; Leibovitch B; Pereira L; Cubedo E; Yu J; Pierzchalski K; Jones JW; Fishel M; Kane M; Zelent A; Waxman S; Farias E
    Oncotarget; 2016 Jul; 7(28):43689-43702. PubMed ID: 27286261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pf1, a novel PHD zinc finger protein that links the TLE corepressor to the mSin3A-histone deacetylase complex.
    Yochum GS; Ayer DE
    Mol Cell Biol; 2001 Jul; 21(13):4110-8. PubMed ID: 11390640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells.
    Kwon YJ; Leibovitch BA; Bansal N; Pereira L; Chung CY; Ariztia EV; Zelent A; Farias EF; Waxman S
    Oncotarget; 2017 Oct; 8(51):88421-88436. PubMed ID: 29179446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
    Farias EF; Petrie K; Leibovitch B; Murtagh J; Chornet MB; Schenk T; Zelent A; Waxman S
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11811-6. PubMed ID: 20547842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer.
    Qiao Y; Shiue CN; Zhu J; Zhuang T; Jonsson P; Wright AP; Zhao C; Dahlman-Wright K
    Oncotarget; 2015 Apr; 6(10):7804-14. PubMed ID: 25762639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.
    Dahiya NR; Leibovitch BA; Kadamb R; Bansal N; Waxman S
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
    Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
    Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the mSin3A PAH2-Pf1 SID1 complex: a Mad1/Mxd1-like interaction disrupted by MRG15 in the Rpd3S/Sin3S complex.
    Kumar GS; Xie T; Zhang Y; Radhakrishnan I
    J Mol Biol; 2011 May; 408(5):987-1000. PubMed ID: 21440557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury.
    Li K; Ying M; Feng D; Chen Y; Wang J; Wang Y
    Oncol Rep; 2016 Apr; 35(4):2405-12. PubMed ID: 26781859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Luo L; Tang H; Ling L; Li N; Jia X; Zhang Z; Wang X; Shi L; Yin J; Qiu N; Liu H; Song Y; Luo K; Li H; He Z; Zheng G; Xie X
    Oncogene; 2018 Nov; 37(47):6166-6179. PubMed ID: 30002443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity.
    Strietz J; Stepputtis SS; Follo M; Bronsert P; Stickeler E; Maurer J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.